Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial

IMPORTANCE: Tourette syndrome is a neurodevelopmental disorder characterized by childhood onset of motor and phonic tics, often accompanied by behavioral and psychiatric comorbidities. Deutetrabenazine is a vesicular monoamine transporter 2 inhibitor approved in the US for the treatment of chorea as...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffey, Barbara, Jankovic, Joseph, Claassen, Daniel O., Jimenez-Shahed, Joohi, Gertz, Barry J., Garofalo, Elizabeth A., Stamler, David A., Wieman, Maria, Savola, Juha-Matti, Gordon, Mark Forrest, Alexander, Jessica K., Barkay, Hadas, Harary, Eran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524312/
https://www.ncbi.nlm.nih.gov/pubmed/34661664
http://dx.doi.org/10.1001/jamanetworkopen.2021.29397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524312/
https://www.ncbi.nlm.nih.gov/pubmed/34661664
http://dx.doi.org/10.1001/jamanetworkopen.2021.29397

Ejemplares similares